Learn More
Medchemexpress LLC Envudeucitinibum | 2417135-66-9 | C22H18D6N6O3 | 1 ML

Supplier: Medchemexpress LLC HY15370110MM/1ML
Envudeucitinibum is a highly selective, allosteric, and orally active TYK2 inhibitor that binds to the JH2 domain of TYK2. It exhibits no off-target effects on other kinases (JAK1-3). It reduces signaling and the production of proinflammatory cytokines including IL-12, IL-23, IL-17, and type I interferons (IFNs). It can be utilized for research related to plaque psoriasis, systemic lupus erythematosus (SLE), and other immune-mediated diseases.
- Highly selective, allosteric, and orally active TYK2 inhibitor
- Binds to the JH2 domain of TYK2
- Exhibits no off-target effects on other kinases (JAK1-3)
- Reduces signaling and production of proinflammatory cytokines
- Potentially useful for research on immune-mediated diseases
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.